Presenting author
Clotilde Guidetti
3 presentations
Strategies to improve treatment effect detection in MDD trials
W34. Esmethadone (REL-1017) in patients with antidepressant tachyphylaxis: A post hoc efficacy analysis in a pre-randomization–defined subgroup
T35. Efficacy and safety of esmethadone (REL-1017) in patients with major depressive disorder and inadequate response to standard antidepressants: Findings from two early-terminated phase 3 trials